Repaglinide powder Raw Materials CAS 135062-02-1

MF:C27H36N2O4

MW:452.59

EINECS:629-921-1

Specification:Repaglinide powder

Sample:Repaglinide powder

Brand:Repaglinide powder

Appearance: powder

Storage: Cool Dry Place

Brand: chemical Raw Materials

Shelf Life: 2 Years

Test Method: HPLC

Uses and synthesis of Repaglinide powder

Repaglinide powder. Commonly used dosage forms are tablets, disperse tablets, etc. It is a hypoglycemic drug. For patients with type 2 diabetes (non-insulin-dependent) whose hyperglycemia is not effectively controlled by diet control, weight loss and exercise. Repaglinide therapy should begin with dietary control and exercise to lower blood sugar during meals. Repaglinide is a diabetes treatment, belonging to non-sulfonylurea insulin releasing agent. Clinically, Repaglinide powder is mainly used to treat patients with type 2 diabetes (non-insulin-dependent) who cannot effectively control hyperglycemia through diet control, weight reduction and exercise.

Applications/Functions of Repaglinide powder

• Repaglinide powder antidiabetic drug. Non-sulfonylurea oral hypoglycemic drugs for the treatment of type 2 diabetes mellitus.
• Repaglinide is used as a hypoglycemic agent

Physicochemical Property of Repaglinide powder

Repaglinide white crystalline powder, odorless. Crystallization from ethanol-water (2:1), melting point 126-128℃. Crystallized from neutral water, melting point 130 ~ 131℃.

Production methodprocess of Repaglinide powder

Compound (Ⅰ) was converted into n-acetyl derivatives, and then separated into (S) type optical isomers by salt formation with L-glutamic acid, then reacted with compound (Ⅱ) to form amide (Ⅲ), and then hydrolyzed to Repaglinide powder.